Back to User profile » Dr Thomas Krieg

Paper published by Dr Thomas Krieg:


Pharmacology and rationale for imatinib in the treatment of scleroderma

Moinzadeh P, Hunzelmann N, Krieg T

Journal of Experimental Pharmacology 2013, 5:15-22

Published Date: 5 April 2013